Basiliximab

Therapeutic Group

Immunosuppressants

Indication Dosage

Prophylaxis Of Acute Rejection In Allogeneic Renal Transplantation Used In Combination With Ciclosporin And Corticosteroid-containing Immunosuppression Regimens: 

By IV Inj Or By IV Infusion: 

  • Adult: Initially 20 Mg, Administered Within 2 Hours Before Transplant Surgery, Followed By 20 Mg After4 Days After Surgery, Withhold Second Dose If Severe Hypersensitivity Or Graft Loss Occurs 
  • Children Above 2 Yrs Weighing Less Than 40 Kg: 10 Mg Per Dose; Weighing 40 Kg Or More, Same As Adult Dose

Content

  • Inj: Basiliximab 20mg; Powder In Vial Plus Diluent

Pregnancy

Consult with Doctor Or Caution Advised

Stability

  • Immunosuppressant
  • Anti-lymphocyte
  • Interleukin-2 Receptor Antagonist

Contra Indications

  • Pregnancy, Lactation For At Least 8 Weeks After The Second Dose.

Precautions

  • Pregnancy, Lactation For At Least 8 Weeks After The Second Dose.

Lactation

  • Consult with Doctor Or Caution Advised

Side Effects

  • Atrial Flutter
  • Cardiac Arrest
  • Cytokine Release Syndrome
  • Palpitations
  • Severe Hypersensitivity Reactions
  • Anaphylactoid Type Reaction Such As Rash
  • Urticaria
  • Sneezing
  • Wheezing
  • Bronchospasm
  • Pulmonary Oedema
  • Cardiac Failure
  • Respiratory Failure And Capillary Leak Syndrome Have Been Reported.

Available Brands